Then, silencing lnc-MAFG-AS1 expression is found to impede the tumor progression of HCC both in vitro and in vivo by interacting with NM IIA subunits (MYH9, MYL12B, and MYL6) (29). The gene discussed is MYL6; the disease is hepatocellular carcinoma.